Coric Vlad Insider Trades

Insider Trading History

Track insider trading activity for Coric Vlad. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $849k 15,343 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254k 4,545 shares
$55.87
$55.34
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $8.13M 550,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.34M 550,000 shares
$11.52
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $26.8M 1,811,398 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$142k 14,250 shares
$9.93
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $421k 28,500 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$142k 14,250 shares
$9.93
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $26.7M 1,803,968 shares
Last Trade
Jan 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$73.8k 7,430 shares
$9.93
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $17.7M 1,195,275 shares
Last Trade
Nov 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5M 666,666 shares
$7.50
$14.78
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $598k 10,798 shares
Last Trade
May 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 7,614 shares
$32.82
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $176k 3,184 shares
Last Trade
Apr 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 3,184 shares
$32.19
$55.34
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Feb 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$54.8k 15,000 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $54.8k 15,000 shares
Last Trade
Feb 04, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$21.1k 5,784 shares
$3.65
$3.65
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $632k 42,750 shares
Last Trade
Jan 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$551k 14,250 shares
$38.64
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $26.6M 1,796,604 shares
Last Trade
Jan 05, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$263k 6,805 shares
$38.64
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $26.7M 1,803,409 shares
Last Trade
Jan 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$551k 14,250 shares
$38.64
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $5.07M 343,000 shares
Last Trade
Jan 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.3M 343,000 shares
$38.64
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $12.7M 861,942 shares
Last Trade
Oct 02, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1M 21,052 shares
$47.50
$14.78
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $85.6k 23,458 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.1k 23,458 shares
$3.80
$3.65
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $26.4M 1,788,417 shares
Last Trade
Apr 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5M 121,951 shares
$41.00
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $4.06M 275,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5M 275,000 shares
$41.93
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $3.33M 225,000 shares
Last Trade
Nov 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.64M 225,000 shares
$29.49
$14.78
Biohaven
Biohaven BHVN
Chief Executive Officer
Holding Value $24.5M 1,657,031 shares
Last Trade
Oct 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10M 454,545 shares
$22.00
$14.78

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up